ArticlePDF Available

Iron deposits in the knee joints of a thalassemic patient

Authors:

Abstract and Figures

The overall prognosis for patients with β-thalassemia has improved considerably during the past decades mainly due to regular blood transfusions, improvements in chelation therapy, and enhanced surveillance with imaging studies examining iron overload and other clinical complications. However, the prolonged survival of these patients leads to the development of other health problems including degenerative diseases such as arthropathies, which require further attention since they have a significant impact on the quality of life. In the current case report, we present a 45-year-old white man with β-thalassemia complaining of non-traumatic pain and restriction in the range of motion of both knees. Magnetic resonance imaging (MRI) revealed a tear in the medial meniscus of the left knee as well as iron deposits in both knees. Histological findings confirmed the presence of hemosiderin in both joints. To our knowledge, this is the first reported case of macroscopically documented iron deposits in the knee joints of a patient with β-thalassemia using MRI.
Content may be subject to copyright.
http://arr.sagepub.com/
Acta Radiologica Short Reports
http://arr.sagepub.com/content/2/1/1
The online version of this article can be found at:
DOI: 10.1177/2047981613477401
2013 2: tActa Radiologica Short Reports
Karantanas
Charalambos P Economides, Elpidoforos S Soteriades, Michalis Hadjigavriel, Ioannis Seimenis and Apostolos
Iron deposits in the knee joints of a thalassemic patient
Published by:
http://www.sagepublications.com
On behalf of:
Nordic Society of Medical Radiology
can be found at:Acta Radiologica Short ReportsAdditional services and information for
http://arr.sagepub.com/cgi/alertsEmail Alerts:
http://arr.sagepub.com/subscriptionsSubscriptions:
http://www.sagepub.com/journalsReprints.navReprints:
http://www.sagepub.com/journalsPermissions.navPermissions:
What is This?
- Feb 1, 2013Version of Record >>
by guest on October 11, 2013arr.sagepub.comDownloaded from by guest on October 11, 2013arr.sagepub.comDownloaded from by guest on October 11, 2013arr.sagepub.comDownloaded from by guest on October 11, 2013arr.sagepub.comDownloaded from by guest on October 11, 2013arr.sagepub.comDownloaded from by guest on October 11, 2013arr.sagepub.comDownloaded from
Case report
Iron deposits in the knee joints of a thalassemic patient
Charalambos P Economides
1,2
, Elpidoforos S Soteriades
1,3
, Michalis Hadjigavriel
4
,
Ioannis Seimenis
5
and Apostolos Karantanas
6
1
Cyprus Institute of Biomedical Sciences (CIBS), Nicosia, Cyprus;
2
Agios Therissos MRI Diagnostic Center, Department of MRI, Nicosia,
Cyprus;
3
Harvard School of Public Health, Department of Environmental Health, Environmental and Occupational Medicine and
Epidemiology (EOME), Boston, MA, USA;
4
Limassol General Hospital, Department of Internal Medicine, Limassol, Cyprus;
5
Democritus
University of Thrace, Medical School, Laboratory of Medical Physics, Alexandroupoli, Greece;
6
University of Crete, Department of Medical
Imaging, Heraklion-Crete, Crete
Correspondence to: Charalambos P Economides. Email: ceconomides@cibs.org.cy
Abstract
The overall prognosis for patients with b-thalassemia has improved considerably during the past decades
mainly due to regular blood transfusions, improvements in chelation therapy, and enhanced surveillance
with imaging studies examining iron overload and other clinical complications. However, the prolonged
survival of these patients leads to the development of other health problems including degenerative
diseases such as arthropathies, which require further attention since they have a significant impact on
the quality of life. In the current case report, we present a 45-year-old white man with b-thalassemia
complaining of non-traumatic pain and restriction in the range of motion of both knees. Magnetic resonance
imaging (MRI) revealed a tear in the medial meniscus of the left knee as well as iron deposits in both knees.
Histological findings confirmed the presence of hemosiderin in both joints. To our knowledge, this is the
first reported case of macroscopically documented iron deposits in the knee joints of a patient with
b-thalassemia using MRI.
Keywords: MR imaging, knee, arthritides, hematologic diseases
Submitted October 7, 2012; accepted for publication January 15, 2013
Patients with thalassemia constitute a significant public
health problem. Providing comprehensive care to such
patients has been viewed by many as a sensitive indicator
of the level and quality of healthcare services in each
country. Blood transfusions and iron overload of liver,
spleen, and heart and their associated complications have
received considerable attention by clinicians and researchers
alike due to their significant impact on morbidity and
mortality of these patients (1, 2). However, as the above
problems have gradually been studied and appropriate
therapies have been introduced in a relatively successful
fashion, contributing to a dramatic increase of patients’
overall survival, other health problems affecting quality
of life eventually may require further attention. Such pro-
blems may be associated with aging and/or degenerative
processes, which appear to have an accelerated pace in
patients with b-thalassemia or may also be related to iron
deposits in other organs including pancreas, pituitary
gland, and joints (3, 4).
Arthropathy is one of the emerging chronic health pro-
blems affecting a significant number of patients with
b-thalassemia, which, so far, has received limited attention
by the scientific, clinical, and public health community
(2, 5 7). Although magnetic resonance imaging (MRI) has
been regularly utilized in assessing iron deposits in liver,
spleen, and heart and to a lesser extent in pancreas and
pituitary gland, no studies have, to date, been published
on the assessment of possible iron deposits in joints of
patients with b-thalassemia (1, 3, 4, 8).
Case report
A 45-year-old white man with b-thalassemia major was
referred for MRI of the left knee due to prominent non-
traumatic chronic medial and lateral pain (past 12 years),
as well as partial locking and restriction in the range of
motion. Neither previous nor recent traumatic knee injury
nor other suspicious events were reported. The patient
had been undergoing regular blood transfusions twice a
month main taining a hemoglobin level of about 9.5 mg/dl
and a ferritin level of 3000 ng/mL. The patient reported
receiving chelation therapy with only oral deferiprone for
Acta Radiologica Short Reports 2013:1. DOI: 10.1177/2047981613477401
the past 13 years at a dose of 75 mg/kg / day. Occasional
chelation with desferioxamine was also used during the
same time period. T2
measurements from previous MRI
examinations on heart and liver are presented in Table 1.
It was evident from the decreasing T2
measurements of
heart and liver, that there was progressive increase in the
degree of iron deposits in the above two org ans in parallel
with clinical observations of poor adherence to chelation
therapy compatible with high levels of plasma ferritin.
Following regular assessment, the patient underwent
MRI of the left knee. Subsequent MR scanning of the right
knee was also performed for comparison purposes.
Written informed consent was obtained from the patient
for publi cation of this manuscript and accompanying
images.
MRI technique
MRI was performed with a 3.0 Tesla scanner (Achieva,
Philips Medical Systems, Best, The Netherlands) to assess
arthropathy including potential iron deposits in the knee
joints. We used the built-in quadrature radiofrequency
(RF) body coil and a phased array 8-channel knee coil for
proton excitation and signal detection, respectively. MRI
scanning protocol included several multislice pulse
sequences routinely performed for morphological imaging
Table 1 Time trends of T2
measurements of liver and heart
Organ
Mean T2
(ms)
2007 2008 2010 2011
Liver
3.8 4.2 1.6 1.6
Heart
18 22 11.3 10.3
Iron deposits assessed by T2
liver measurements range from mild to
moderate severity. Liver measurements were obtained from a region of
interest prescribed in the segment V/VIII of the right liver lobe
Iron deposits assessed by T2
heart measurements range from normal
to moderate severity. Heart measurements were obtained from a region of
interest prescribed in the intraventricular region
Fig. 1 A fat-suppressed, PD-w image in the coronal plane of the left knee
shows a longitudinal tear in the body of medial meniscus (long arrow) and
the displaced meniscal fragment within the intercondylar notch (short
arrow). In addition, osteoarthritic changes with minimal subcortical cyst
formations and reactive bone marrow edema are noted in the medial
tibial plateau (open arrow)
Fig. 2 (a) A T2
-w sagittal image in the left knee represents foci of iron
deposits within the supra patellae pouch right above the superior pole of
the patellae (short arrow) and also in contact with the patellae cartilage at
the upper pole (long arrow), as well as within the Hoffa’s fat pad in contact
with the patellae cartilage in its inferior pole (open arrow) and in the cartilage
surface over the trochlea (doted arrow). (b) A fat-suppressed PD-w image in
the sagittal plane in the left knee shows foci of iron deposition along the
surface of the cartilage over the lateral trochlea (short arrow). We note
the drop of signal in the area of iron deposits, which is less prominent in
comparison with the corresponding T2
-w image
2 CP Economides et al.
.................................................................................................................................................
(in each case, 28 slices were acquired with a field-of-view
of 170 mm, a section thickness of 2.8 mm, and a pixel size
of 0.6 0.7 mm); T1-weighted (T1-w) (repetition time
[TR], 674 ms; echo time [TE], 18 ms; total scan time [ST],
2.5 min) turbo spin echo (TSE) in the sagittal plane;
T2
-weighted (T2
-w) (TR, 575 ms; TE, 12 ms; ST, 2.4 min)
gradient recalled echo (GRE) in the axial plane; proton
density-weighted (PD-w) (TR, 2342 ms; TE, 35 ms; ST,
2.9 min) TSE with spectral fat suppression in the coronal
and axial planes. Three-dimensional (3D) susceptibility
weighted imaging (SWI) and ultra short echo time (UTE)
GRE pulse sequences were also prescribed in the axial
plane. The former utilizes an echo-shifting technique that
allows the employment of relatively long ec ho times (TE,
21 ms) in a time-efficient way (TR, 15 ms; ST, 1.5 min for
100 slices with an acquisition resolution of 1 1 2 mm).
The latter uses a radial data sampling technique achieving
an ultra short TE of 14
m
s (TR, 7.5 ms; ST, 9.8 min; 144
slices; 1 mm
3
acquisition voxel size). The sequence used
for quantitative T2 measurements was also prescribed
in the sagittal plane. A single-slice (acquisition voxel size
of 0.5 0.5 5.0 mm) Carr Purcel Meibomm Gill (CPMG)
spin echo sequence employing 16 equidistant echoes, a
short echo spacing of 6 ms and a TR of 2s was used
(ST, 5.7 min).
MRI findings in the left knee
Left knee MR images revealed several pathological findings
compatible with the prominent clinical symptomatology.
The imaging findings included a flap tear of the medial
meniscus with a displaced meniscal fragment in the
medial intercondylar notch (Fig. 1). In addition, osteo-
arthritis was noted in the medial joint compartment with
marked attenuation of the articular cartilage, reactive
subcortical bone marrow edema in the medial tibial
plateau, and minimal subcortical cystic changes (Fig. 1).
Furthermore, there was mild attenuation of the patellar car-
tilage indicating chondromalacia patellae grade II. Foci of
iron deposits were identified macroscopically within the
supra-patellar pouch right above the superior pole of the
patellae and also in contact with the patellae cartilage at
the upper pole, as well as within the Hoffa’s fat pad in
contact with the patellae cartilage in its inferior pole and
in the cartilage surface over the trochlea (Fig. 2a). Finally,
iron deposits were also noted along the surface of the
medial plica in the supra-patellar pouch. The iron deposits
were detected as low signals intensity foci in all MRI
sequences used. However, iron deposits were less conspicu-
ous on the T1-w and PD-w sequences, with particular signal
loss on gradient echo (Fig. 2B). During the above study we
Fig. 3 This image represents four corresponding axial images from different pulse sequences of the left knee. (a) is a T2
-w image, (b) is an ultra short time echo
(UTE) image, (c) was obtained with susceptibility weighted imaging (SWI), and (d) represents PD-w imaging with a turbo spin echo sequence. In (a), we note a
large area of iron deposit in contact with the patellae and trochlea groove cartilage presented as a low signal intensity focus (arrow). In (b) and (c) we highlight a
further exaggeration of the signal loss in the area of iron deposits on the UTE and SWI sequences, respectively (arrows). In (d) we note less conspicuous signal
loss of the iron deposit area in the PD-w sequence (arrow)
Iron deposits in the knee joints of a thalassemic patient 3
.................................................................................................................................................
also noticed further exaggeration of the signal loss on the
SWI and UTE sequences (Fig. 3). In Table 2 we present
mean T2 measurements for regions of interest prescribed
in different areas of the cartilage in the left knee. The T2
measurement of normal Hoffa’s fat pad was 215 ms
(18.8 SD), while in Hoffas fat pad with iron deposits T2
measurement was 54.8 ms (11 SD) and in the supra-patellar
pouch with iron deposits T2 was 51.1 ms (4.4 SD), respect-
ively. Such findings indicate iron deposits in the above
regions with decreased T2 measurements.
MRI of the right knee was also performed mainly for
comparison purposes. Iron deposits were also noted in the
right knee (Fig. 4). Iron deposits were noted in contact
with the inferior pole of the patellar cartilage, as well as in
contact with the anterior articular surface of the lateral
femoral condyle.
Histology results
Following MRI studies, the patient underwent an arthro-
scopy of the left knee in order to explore the pathological
imaging findings and repair the meniscal tear. Biopsy
of the synovium showed edema of the basal membrane
with papillary morphology and hemosiderin deposits.
Histiocytes with hemosiderin moietie s were also noted
along with hyperplastic serous cells.
Discussion
To our knowledge, this is the first reported case of iron
deposits in the knee joint of a patient with b-thalassemia
major potentially associated with clinical symptoms. Our
case report poses an important question regarding the
prevalence of iron deposits in knee and other major joints
of patients with b-thalassemia major, especially those of
the lower extremities. In addition, this particular case
raises furthe r clinical concerns as to whether iron deposits
in joints may be associated with clinical arthropathy in
such patients. Furthermore, we pose a scientific question
on the potential association of iron deposits in joints
leading to the development of synovitis and/or cartilage
damage (2, 57). Finally, our findings lead to significant
clinical questions with respect to the effectiveness of the tra-
ditional chelation therapy to remove iron deposits from the
joints of patients with b-thalassemia.
The examination of our case was facilitated by MRI tech-
niques based on the GRE method that allow the visualiza-
tion of small foci of iron deposits. Such techniques include
the traditional T2
-w as well as the novel UTE and SWI
methods (9). The high sensitivity of the UTE pulse sequence
to iron is due to the ultra short echo time that employs,
which allows visualization of short T2 spe cies. SWI is
also a relatively new MRI sequence, which evaluates and
exploits the magnetic properties of tissues. Paramagnetic
substances like deoxyhemoglobin, a product of blood de-
gradation, and ferritin, a non-heme iron, are known
sources of magnetic susceptibility in the tissues and they
appear as hypointense foci. Albeit the high sensitivity
of UTE and SWI sequences in the detection of iron
deposits, CPMG and GRE sequences are more suited for
quantitative imaging in tissues, since the presence of para-
magnetic species reduce regional transverse relaxation
times. Therefore, T2 and T2
measurements are widely
used for liver and heart iron load evaluation.
As UTE and SWI are much more sensitive at lower con-
centrations of iron, they can be used to detect small foci of
iron deposits that conventional spin echo and GRE pulse
sequences fail to depict. In addition, because of their 3D
nature, UTE and SWI offer the possibility of rigorous and
thorough inspection of the joint for iron. Thus, they can
effectively guide the correct prescription of the single-slice
sequences used for quantitative transverse relaxation time
measurements. Due to the negative contrast effect of iron
foci, a major challenge is to distinguish regions of signal
void due to iron from those due to low signal tissues or sus-
ceptibility artifacts. Therefore, T2 measurements were only
performed at regions which appeared hypointense in both
UTE and SWI images.
MRI and the documented pathological picture of the left
knee, excluding the meniscal flap tear, showed advanced
Fig. 4 AT2
-w sagittal image of the right knee obtained with a gradient
recalled echo (GRE) pulse sequence. Iron deposits are noted in contact
with the inferior pole of the patellae cartilage (short arrow), as well as in
contact with the anterior cartilage surface of the lateral femoral condyle
(long arrow)
Table 2 Measurements of T2 in different areas of the cartilage of the
left knee
Mean T2 (SD) (ms)
Patella
Lateral
trochlea
Articular
surface
(lateral
femoral
condyle)
Articular
surface
(lateral
tibial
plateau)
Time (ms) 60 (11.5) 79 (8.8) 63 (18.6) 40 (8.9)
4 CP Economides et al.
.................................................................................................................................................
degenerative changes, which are thought to be non-
compatible with the patient’s age and clinical history. This
is an interesting finding in view of the macroscopically
noted iron deposits and the poor adherence to chelation
therapy. Further studies are warranted in order to examine
the prevalence of iron deposits in the joints of patients
with b-thalassemia and their potential association with
accelerated degenerative chang es especially in the lower
extremities. In addition , there should be enhanced clinical
interest on the evaluation of the effectiveness of chelation
therapy for removing iron deposits from joints in a similar
fashion with other organs such as liver and heart.
Our case report, although raising important epidemiolo-
gical and clinical questions, may not be representative of
the majority of patients with b-thalassemia in the developed
countries, where patients may adhere to chelation therapy,
since the particular patient had a poor adherence to chela-
tion treatment. An additional limitation of our case may
be associated with our inability to dissociate the do-
cumented clinical pathology in the knee joint with the
degenerative changes and allocate potential partial etiology
to iron deposits. Although the case is an interesting example
of iron deposits in knee joints, the causal relationship with
arthropathy/meniscal rupture documented with MRI and
arthroscopy is purely speculative. Further epidemiological
studies with case series, case-control, and cohort studies
are warranted to explore the above scientific questions.
In conclusion, our case report highlights a new and
emerging chronic problem of patients with b-thalassemia;
namely arthropathy, which may be potentially related to
accelerated degenerative changes in the joints of the above
patients in association with iron deposits.
ACKNOWLEDGEMENTS
The authors thank Philips Medical Systems Inc., Best, The
Netherlands for their kind provision of the ultra short
TE pulse sequence.
REFERENCES
1 Anderson LJ, Westwood MA, Prescott E, et al. Development of
thalassaemic iron overload cardiomyopathy despite low liver iron
levels and meticulous compliance to desferrioxamine. Acta Haematol
2006;115:1068
2 Chan Y, Li C, Chu WC, et al. Deferoxamine induced bone dysplasia
in the distal femur and patella of pediatric patients and young
adults: MR Imaging Appearance. Am J Roentgenol 2000;175:15616
3 Anderson LJ, Westwood MA, Holden S, et al. Myocardial iron clearance
during reversal of siderotic cardiomyopathy with intravenous
desferrioxamine: a prospective study using T2
cardiovascular magnetic
resonance. Br J Haematol 2004;127:34855
4 de Assis RA, Ribeiro AA, Kay FU, et al. Pancreatic iron stores assessed
by magnetic resonance imaging (MRI) in beta thalassemic patients.
Eur J Radiol 2012;81:146570
5 Chand G, Chowdhury V, Manchanda A, et al. Deferiprone-induced
arthropathy in thalassemia: MRI findings in a case. Indian J Radiol Imaging
2009;19:1557
6 Berkovitch M, Laxer RM, Inman R, et al. Arthropathy in thalassemia
patients receiving deferiprone. Lancet 1994;343:1471 2
7 Kellenberger JC, Schmugge M, Saurenmann T. Radiographic and MRI
features of deferiprone related arthtropathy of the knees in patients with
b- thalassaemia. Am J Roentgenol 2004;182:989 94
8 Noetzli LJ, Panigrahy A, Mittelman SD, et al. Pituitary iron and volume
predict hypogonadism in tranfusional iron overload. Am J Hematol 2011
Nov 4 [Epub ahead of print]
9 Hall-Craggs MA, Porter J, Gatehouse PD, et al. Ultrashort echo time (UTE)
MRI of the spine in thalassaemia. Br J Radiol 2004;77:104 10
# 2013 The Foundation Acta Radiologica
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.
org/licenses/by-nc/2.0/), which permits non-commercial use, distribution and reproduction in any medium, provided the original
work is properly cited.
Iron deposits in the knee joints of a thalassemic patient 5
.................................................................................................................................................
... Organ damage in iron-overloaded conditions is progressively developed and can reach different stages, which in general depends on the level of iron load. Early stages of damage in patients' organs can be detectable when approximately 20-50 units of RBC have been transfused [9,29,[90][91][92][93][94][95][96]. At these early stages the organ damage can be reversible provided effective iron chelation therapy protocols are applied. ...
... The concentration of excess iron in the heart was, until recently, impossible to identify by using biopsies or other methods. Furthermore, the introduction of the MRI T2 and T2* techniques have successfully been used for estimating the level of iron loading not only in the heart but also in the liver, spleen, pancreas, and other organs (Figure 3d) [39,96,100,104,[108][109][110]. ...
Article
Full-text available
Iron is essential for all organisms and cells. Diseases of iron imbalance affect billions of patients, including those with iron overload and other forms of iron toxicity. Excess iron load is an adverse prognostic factor for all diseases and can cause serious organ damage and fatalities following chronic red blood cell transfusions in patients of many conditions, including hemoglobinopathies, myelodyspasia, and hematopoietic stem cell transplantation. Similar toxicity of excess body iron load but at a slower rate of disease progression is found in idiopathic haemochromatosis patients. Excess iron deposition in different regions of the brain with suspected toxicity has been identified by MRI T2* and similar methods in many neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease. Based on its role as the major biological catalyst of free radical reactions and the Fenton reaction, iron has also been implicated in all diseases associated with free radical pathology and tissue damage. Furthermore, the recent discovery of ferroptosis, which is a cell death program based on free radical generation by iron and cell membrane lipid oxidation, sparked thousands of investigations and the association of iron with cardiac, kidney, liver, and many other diseases, including cancer and infections. The toxicity implications of iron in a labile, non-protein bound form and its complexes with dietary molecules such as vitamin C and drugs such as doxorubicin and other xenobiotic molecules in relation to carcinogenesis and other forms of toxicity are also discussed. In each case and form of iron toxicity, the mechanistic insights, diagnostic criteria, and molecular interactions are essential for the design of new and effective therapeutic interventions and of future targeted therapeutic strategies. In particular, this approach has been successful for the treatment of most iron loading conditions and especially for the transition of thalassemia from a fatal to a chronic disease due to new therapeutic protocols resulting in the complete elimination of iron overload and of iron toxicity.
... Magnetic resonance imaging (MRI) is the preferred modality for non-invasive evaluation of the knee joint. Common fluid sensitive techniques used in routine knee MRI include inversion recovery (STIR), fat-suppressed proton density (fsPDW) and fat-suppressed intermediate weighted (echo times [35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50] sequences. Some institutes also use T2W sequence with or without fat suppression. ...
... Primary haemochromatosis is an autosomal recessive genetic disorder while secondary haemochromatosis is due to any acquired condition that causes increased iron levels, such as cirrhosis, myelodysplastic syndromes, thalassaemia or exogenous iron administration. Thalassaemia therapy encompassing repeated blood transfusions commonly results in synovial deposition of hemosiderin in the knee joint [35]. Haemophilia is another genetic disorder that leads to blood clotting disturbance and repeated haemorrhages within various tissues of the body, including joints. ...
Article
Full-text available
The majority of abnormal findings or lesions on T2-weighted fast spin-echo (FSE) magnetic resonance imaging (MRI) are hyperintense due to increased perfusion or fluid content, such as infections, tumours or synovitis. Hypointense lesions on T2-weighted images (both fat-suppressed and non-fat-suppressed) are less common and can sometimes be overlooked. Such lesions have limited differential diagnostic possibilities, and include vacuum phenomenon, loose body, tenosynovial giant cell tumour, rheumatoid arthritis, haemochromatosis, gout, amyloid, chondrocalcinosis, hydroxyapetite deposition disease, lipoma arborescens, arthrofibrosis and iatrogenic lesions. These lesions often show characteristic appearances and predilections in the knee. In this article, the authors describe the MRI features of hypointense T2 lesions on routine knee MRI and outline a systematic diagnostic approach towards their evaluation. Key Points • Hypointense lesions on T2 images (T2 Dark Lesions) encompass limited diagnostic possibilities. • T2 Dark lesions often show characteristic appearances and predilections in the knee. • A systematic diagnostic approach will help radiologists make the correct diagnosis.
... In some TM patients the presence of excess focal deposited iron, irrespective of the total body iron load can also cause tissue damage. Excess iron has for example been observed in the joints of some TM patients using MRI T2* with associated knee and ankle complications [59]. It should be noted that focal iron deposition and associated complications have also been observed in the brain of patients with neurodegenerative diseases, such as Friedreich ataxia, Alzheimer's and Parkinson's diseases [60][61][62]. ...
Article
Full-text available
Beta thalassaemia major (TM), a potentially fatal haemoglobinopathy, has transformed from a fatal to a chronic disease in the last 30 years following the introduction of effective, personalised iron chelation protocols, in particular the use of oral deferiprone, which is most effective in the removal of excess iron from the heart. This transition in TM has been achieved by the accessibility to combination therapy with the other chelating drugs deferoxamine and deferasirox but also therapeutic advances in the treatment of related co-morbidities. The transition and design of effective personalised chelation protocols was facilitated by the development of new non-invasive diagnostic techniques for monitoring iron removal such as MRI T2*. Despite this progress, the transition in TM is mainly observed in developed countries, but not globally. Similarly, potential cures of TM with haemopoietic stem cell transplantation and gene therapy are available to selected TM patients but potentially carry high risk of toxicity. A global strategy is required for the transition efforts to become available for all TM patients worldwide. The same strategy could also benefit many other categories of transfusional iron loaded patients including other thalassaemias, sickle cell anaemia, myelodysplasia and leukaemia patients.
... 12,37,38 Besides HH, symptoms of degenerative arthropathy and morphological/biochemical changes in articular cartilage have been documented in other conditions associated with disrupted iron metabolism such as hemophilic arthropathy and thalassemia, where the joints are exposed to abnormally high iron levels. 39,40 Unlike the HH arthropathy type which is induced by iron overload (nonhaem), arthropathy associating with hemophilia is often triggered by bleeding (haem iron involvement) and is exacerbated by neovascularization in the damaged joints. 41 Experimental studies involving guinea pigs and parameters were within normal range. ...
Article
Arthropathy or joint disease leads to significant pain and disability irrespective of aetiology. Clinical and experimental evidence point to the presence of considerable links between arthropathy and iron overload. Previous work has suggested that iron accumulation in the joints often associates with increased oxidative stress, disrupted matrix metabolism and cartilage degeneration. However, key issues regarding the role of iron overload in the pathogenesis of arthropathy remain ambiguous. For example, significant gaps in our knowledge of the primary cellular targets of iron overload‐induced damage and the exact molecular mechanism through which disrupted iron homeostasis leads to joint damage still exist. The exact signalling pathway that links iron metabolism and cellular damage in arthropathy also remains largely unmapped. In this review, we focus on the relationship between iron overload and arthropathy with special emphasis on the adversarial relationship between iron that accumulates in the joints over time and cartilage homeostasis. A better understanding of the mechanisms and pathways underlying iron‐induced cartilage degeneration may help in defining new prognostic markers and therapeutic targets in arthropathy. This article is protected by copyright. All rights reserved.
... A strong correlation between iron overload and cartilage degeneration leading to OA has been documented (Burton et al., 2020;Ferreira et al., 2021). Besides HH, degenerative cartilage changes and OA-like arthropathy have been reported in other clinical conditions such as haemophilia and thalassemia (Roosendaal et al., 1999;Economides et al., 2012) where joint structures are usually exposed to high systemic iron levels. However, chelation of excessive systemic iron does not improve the symptoms of joint arthropathy (Husar-Memmer et al., 2014), suggesting that joint damage under conditions of iron overload relates more to iron sequestered in the joint tissues rather than systemic iron levels. ...
Article
Full-text available
Clinical and experimental evidence point to the presence of considerable links between arthropathy, osteoarthritis (OA) in particular, and iron overload possibly due to oxidative stress and tissue damage. However, the specific cellular targets of iron overload-related oxidative stress in OA remain ambiguous . We examined the effects of iron overload on chondrocyte health using the C-20/A4 chondrocyte cell line. Cells were treated with increasing concentrations of ferric ammonium citrate (FAC) to mimic iron overload in vitro . Treated cells were assessed for cell viability, cycling, apoptosis, collagen II synthesis, and oxidative stress along with cellular iron content and the expression of key iron regulatory genes. FAC treatment resulted in an increase in ferritin expression and a significant decrease in the expression of hepcidin, ferroportin, transferrin receptors 1 (TfR1) and TfR2. Increased labile iron content was also evident, especially in cells treated with high FAC at 24 h. High doses of FAC treatment also induced higher levels of reactive oxygen species, reduced collagen II production, disrupted cell cycle and higher cell death as compared with untreated controls. In conclusion, findings presented here demonstrate that iron overload disrupts cellular iron homeostasis, which compromises the functional integrity of chondrocytes and leads to oxidative stress and apoptosis.
... 17,23 The exposure of wt and Hfe-KO chondrocytes to ferric citrate loads favored iron accumulation and the development of an OA-similar phenotype, which is in agreement with what was described previously with the identification of iron deposits in the articular cartilage and synovial membrane of HFE-hemochromatosis patients and cartilage-associated degradation. [69][70][71] Iron deposits were also detected in thalassemia patients' articulation, 72 suggesting the putative toxic effect of iron overload inside articulations. Epidemiology studies report high prevalence of OA-associated HFEhemochromatosis in patients averaging 60 years of age, with a strong association between transferrin saturation and serum ferritin concentrations. ...
Article
HFE‐hemochromatosis is a disease characterized by a systemic iron overload phenotype mainly associated with mutations in the HFE protein (HFE) gene. Osteoarthritis (OA) has been reported as one of the most prevalent complications in HFE‐hemochromatosis patients, but the mechanisms associated with its onset and progression remain incompletely understood. In this study, we have characterized the response to high iron concentrations of a primary culture of articular chondrocytes isolated from newborn Hfe‐KO mice and compared the results with that of a similar experiment developed in cells from C57BL/6 wild‐type (wt) mice. Our data provide evidence that both wt‐ and Hfe‐KO‐derived chondrocytes, when exposed to 50 μM iron, develop characteristics of an OA‐related phenotype, such as an increased expression of metalloproteases, a decreased extracellular matrix production, and a lower expression level of aggrecan. In addition, Hfe‐KO cells also showed an increased expression of iron metabolism markers and MMP3, indicating an increased susceptibility to intracellular iron accumulation and higher levels of chondrocyte catabolism. Accordingly, upon treatment with 50 μM iron, these chondrocytes were found to preferentially differentiate toward hypertrophy with increased expression of collagen I and transferrin and downregulation of SRY (sex‐determining region Y)‐box containing gene 9 (Sox9). In conclusion, high iron exposure can compromise chondrocyte metabolism, which, when simultaneously affected by an Hfe loss of function, appears to be more susceptible to the establishment of an OA‐related phenotype.
Article
Full-text available
The design of clinical protocols and the selection of drugs with appropriate posology are critical parameters for therapeutic outcomes. Optimal therapeutic protocols could ideally be designed in all diseases including for millions of patients affected by excess iron deposition (EID) toxicity based on personalised medicine parameters, as well as many variations and limitations. EID is an adverse prognostic factor for all diseases and especially for millions of chronically red-blood-cell-transfused patients. Differences in iron chelation therapy posology cause disappointing results in neurodegenerative diseases at low doses, but lifesaving outcomes in thalassemia major (TM) when using higher doses. In particular, the transformation of TM from a fatal to a chronic disease has been achieved using effective doses of oral deferiprone (L1), which improved compliance and cleared excess toxic iron from the heart associated with increased mortality in TM. Furthermore, effective L1 and L1/deferoxamine combination posology resulted in the complete elimination of EID and the maintenance of normal iron store levels in TM. The selection of effective chelation protocols has been monitored by MRI T2* diagnosis for EID levels in different organs. Millions of other iron-loaded patients with sickle cell anemia, myelodysplasia and haemopoietic stem cell transplantation, or non-iron-loaded categories with EID in different organs could also benefit from such chelation therapy advances. Drawbacks of chelation therapy include drug toxicity in some patients and also the wide use of suboptimal chelation protocols, resulting in ineffective therapies. Drug metabolic effects, and interactions with other metals, drugs and dietary molecules also affected iron chelation therapy. Drug selection and the identification of effective or optimal dose protocols are essential for positive therapeutic outcomes in the use of chelating drugs in TM and other iron-loaded and non-iron-loaded conditions, as well as general iron toxicity.
Article
Purpose: To visualize healthy and abnormal articular cartilage, we investigated the potential of using the 3D multi-echo gradient echo (GRE) signal's magnitude and frequency and maps of T2* relaxation. Materials and methods: After optimizing imaging parameters in five healthy volunteers, 3D multi-echo GRE magnetic resonance (MR) images were acquired at 3T in four patients with chondral damage prior to their arthroscopic surgery. Average magnitude and frequency information was extracted from the GRE images, and T2* maps were generated. Cartilage abnormalities were confirmed after arthroscopy and were graded using the Outerbridge classification scheme. Regions of interest were identified on average magnitude GRE images and compared to arthroscopy. Results: All four patients presented with regions of Outerbridge Grade I and II cartilage damage on arthroscopy. One patient had Grade III changes. Grade I, II, and III changes were detectable on average magnitude and T2* maps, while Grade II and higher changes were also observable on MR frequency maps. For average magnitude images of healthy volunteers, the signal-to-noise ratio of the magnitude image averaged over three echoes was 4.26 ± 0.32, 12.26 ± 1.09, 14.31 ± 1.93, and 13.36 ± 1.13 in bone, femoral, tibial, and patellar cartilage, respectively. Conclusion: This proof-of-principle study demonstrates the feasibility of using different imaging contrasts from the 3D multi-echo GRE scan to visualize abnormalities of the articular cartilage. © 2016 International Society for Magnetic Resonance in Medicine Level of Evidence: 1 J. MAGN. RESON. IMAGING 2017;45:1502-1513.
Article
Full-text available
Arthropathy is a well known side effect of the iron chelator deferiprone (L1); however, the imaging findings in deferiprone-induced arthropathy are not well known. In this article, we describe the typical radiographic and MRI findings in a patient receiving regular blood transfusions who developed arthropathy after long-term therapy with the oral iron chelator deferiprone (L1). Deferiprone primarily affects the articular cartilage and the changes include synovial thickening, articular cartilage thickening, and subchondral bone erosions.
Article
Heart failure from iron overload causes 71% of deaths in thalassaemia major, yet reversal of siderotic cardiomyopathy has been reported. In order to determine the changes in myocardial iron during treatment, we prospectively followed thalassaemia patients commencing intravenous desferrioxamine for iron-induced cardiomyopathy during a 12-month period. Cardiovascular magnetic resonance assessments were performed at baseline, 3, 6 and 12 months of treatment, and included left ventricular (LV) function and myocardial and liver T2*, which is inversely related to iron concentration. One patient died. The six survivors showed progressive improvements in myocardial T2* (5.1 +/- 1.9 to 8.1 +/- 2.8 ms, P = 0.003), liver iron (9.6 +/- 4.3 to 2.1 +/- 1.5 mg/g, P = 0.001), LV ejection fraction (52 +/- 7.1% to 63 +/- 6.4%, P = 0.03), LV volumes (end diastolic volume index 115 +/- 17 to 96 +/- 3 ml, P = 0.03; end systolic volume index 55 +/- 16 to 36 +/- 6 ml, P = 0.01) and LV mass index (106 +/- 14 to 95 +/- 13, P = 0.01). Iron cleared more slowly from myocardium than liver (5.0 +/- 3.3% vs. 39 +/- 23% per month, P = 0.02). These prospective data confirm that siderotic heart failure is often reversible with intravenous iron chelation with desferrioxamine. Myocardial T2* improves in concert with LV volumes and function during recovery, but iron clearance from the heart is considerably slower than from the liver.
Article
Hypogonadism is the most common morbidity in patients with transfusion-dependent anemias such as thalassemia major. We used magnetic resonance imaging (MRI) to measure pituitary R2 (iron) and volume to determine at what age these patients develop pituitary iron overload and volume loss. We recruited 56 patients (47 with thalassemia major, five with chronically transfused thalassemia intermedia and four with Blackfan-Diamond syndrome) to have pituitary MRIs to measure pituitary R2 and volume. Hypogonadism was defined clinically based on the timing of secondary sexual characteristics or the need for sex hormone replacement therapy. Patients with transfusional iron overload begin to develop pituitary iron overload in the first decade of life; however, clinically significant volume loss was not observed until the second decade of life. Severe pituitary iron deposition (Z > 5) and volume loss (Z < -2.5) were independently predictive of hypogonadism. Pituitary R2 correlated significantly with serum ferritin as well as liver, pancreatic, and cardiac iron deposition by MRI. Log pancreas R2* was the best single predictor for pituitary iron, with an area under the receiving operator characteristic curve of 0.88, but log cardiac R2* and ferritin were retained on multivariate regression with a combined r(2) of 0.71. Pituitary iron overload and volume loss were independently predictive of hypogonadism. Many patients with moderate-to-severe pituitary iron overload retained normal gland volume and function, representing a potential therapeutic window. The subset of hypogonadal patients having preserved gland volumes may also explain improvements in pituitary function observed following intensive chelation therapy. Am. J. Hematol. 2011. © 2011 Wiley Periodicals, Inc.
Article
To assess the correlation between MRI findings of the pancreas with those of the heart and liver in patients with beta thalassemia; to compare the pancreas T2* MRI results with glucose and ferritin levels and labile plasma iron (LPI). We retrospectively evaluated chronically transfused patients, testing glucose with enzymatic tests, serum ferritin with chemiluminescence, LPI with cellular fluorescence, and T2* MRI to assess iron content in the heart, liver, and pancreas. MRI results were compared with one another and with serum glucose, ferritin, and LPI. Liver iron concentration (LIC) was determined in 11 patients' liver biopsies by atomic absorption spectrometry. 289 MRI studies were available from 115 patients during the period studied. 9.4% of patients had overt diabetes and an additional 16% of patients had impaired fasting glucose. Both pancreatic and cardiac R2* had predictive power (p<0.0001) for identifying diabetes. Cardiac and pancreatic R2* were modestly correlated with one another (r(2) = 0.20, p<0.0001). Both were weakly correlated with LIC (r(2) = 0.09, p<0.0001 for both) and serum ferritin (r(2) = 0.14, p<0.0001 and r(2) = 0.03, p<0.02, respectively). None of the three served as a screening tool for single observations. There is a strong log-log, or power-law, relationship between ratio of signal intensity (SIR) values and pancreas R2* with an r(2) of 0.91. Pancreatic iron overload can be assessed by MRI, but siderosis in other organs did not correlate significantly with pancreatic hemosiderosis.
Article
The iron chelator deferiprone (L1) reduces tissue iron stores in iron-loaded patients. Three of sixteen patients treated with deferiprone developed joint pain and swelling without evidence of systemic lupus erythematosus (SLE). Articular cartilage, synovial hypertrophy and iron deposition, and synovial lining cell proliferation, with no inflammatory or allergic reaction, were observed on synovial exploration and biopsy. Symptoms resolved partly or completely during continued drug administration. We hypothesise that deferiprone-induced shifts of iron to synovium resulted in tissue damage, accelerated by free-radical formation during incomplete complexation of iron and this bidentate chelator. This deferiprone-associated symptom complex is not associated with drug-induced SLE, and does not progress in severity during continued therapy.
Article
We investigated the MR imaging appearance of deferoxamine-induced bone dysplasia in the distal femur and patella in patients with thalassemia major. Thirty-five patients with homozygous ss-thalassemia major who were undergoing regular transfusions and chelation therapy underwent coronal T1-weighted MR imaging of the femur, including the femoral head and the distal femoral epiphysis. Additional coronal fat-saturated dual-echo and sagittal T1-weighted images of the distal femur and patella were obtained in 11 patients who were suspected of having distal femoral lesions on the basis of the coronal T1-weighted images of the entire femur. No dysplastic change was detected in the proximal femur on coronal T1-weighted images. In 22 distal femurs of 11 patients, the following abnormalities were detected on MR imaging: blurred physeal-metaphyseal junction (n = 22), distal metaphyseal areas of hyperintensity (n = 21), physeal widening (n = 18), metadiaphyseal lesions (n = 11), epiphyseal lesions (n = 10), and patellar lesions (n = 2). Physeal widening and distal metaphyseal hyperintense areas were all more pronounced peripherally. Of the 21 distal metaphyseal hyperintensities, lateral abnormalities were larger than medial abnormalities in 16. Of the 18 distal femurs in which physeal widening was detected, the lateral widening was more marked than the medial widening in 12. Patients with MR imaging evidence of bone dysplasia have a significantly (p = 0.003) greater height reduction than patients without such evidence of bone dysplasia. Deferoxamine-induced bone dysplasia in the distal femur and patella is represented by a spectrum of morphologic changes in the epiphysis, physis, metaphysis, and metadiaphysis on MR imaging.
Article
Back pain is common in adult patients with homozygous thalassaemia, and degenerative disc disease is increasingly recognised as a cause. Ultrashort echo time (UTE) pulse sequences, which are sensitive to the presence of short T(2) relaxation components in tissue produced by iron deposition and other processes, were used to examine the lower thoracic and lumbar spine in symptomatic patients with beta-thalassaemia major or intermedia. Three patients were studied with fat suppressed as well as both fat suppressed and long T(2) suppressed UTE (TE=0.08 ms) pulse sequences. Conventional 2D Fourier transformation T(1) and T(2) weighted scans were also performed for comparison. Normal controls showed narrow high signal areas in the region of the end-plate and annulus fibrosus. Patients showed hyperintense bands adjacent to the vertebral end plate in lower thoracic and lumbar spine discs using a UTE sequence with both long T(2) component and fat suppression. The extent of the changes was most marked in the patient with the most severe degenerative change. In the patient with minimal disease, findings of this type were present in discs which did not show evidence of degeneration with conventional MR imaging. High signal changes of a type previously not described were observed in each patient. The effect may be due to organic iron entering the disc and decreasing its T(1) and T(2), but susceptibility effects from iron in the vertebral bodies, fibrosis and other causes also need to be considered.
Article
This study was undertaken to describe the radiographic and MRI appearances of arthropathy of the knees in 14 patients with beta-thalassemia major undergoing chelation therapy with deferiprone (L1). All available radiographs and MRI studies of the knees in 14 beta-thalassemia major patients (mean age, 16.3 years; age range, 7-33 years) undergoing chelation therapy with L1 were retrospectively assessed for changes in the synovium, cartilage, and bone. Imaging findings and signs of knee arthropathy were correlated with chelation therapy and average serum ferritin concentration. Nine (64%) of the 14 patients developed arthralgia of the knees during treatment with L1. Abnormal imaging findings were present in all symptomatic and two asymptomatic patients (12/14, 86%) and included joint effusion, subchondral bone irregularity, and patellar beaks. Additional MRI findings were thickening and enhancement of the synovium; hypointense bands in the synovium; irregularly thickened epiphyseal and articular cartilage overlying subchondral bone defects; and, on T2-weighted sequences, hyperintense articular cartilage lesions. The degree of knee symptoms at the time of imaging did not reflect the severity of cartilage and subchondral bone changes. Radiologic changes can be seen in L1-related arthropathy and should be recognized. MRI of the knees should be considered in symptomatic children and young adults with thalassemia undergoing L1 chelation therapy for iron overload.
Article
It is believed that myocardial iron deposition and the resultant cardiomyopathy only occur in the presence of severe liver iron overload. Using cardiovascular magnetic resonance, it is now possible to assess myocardial and liver iron levels as well as cardiac function in the same scan, allowing this supposition to be examined. We describe a patient with progressive myocardial iron deposition and the development of early iron overload cardiomyopathy despite excellent compliance to standard subcutaneous desferrioxamine, minimal liver iron and well-controlled serum ferritin levels. These indirect markers remained far below the thresholds conventionally believed to be associated with increased cardiac risk.